Clinical Efficacy of a 3D Foot Scanner for the Therapeutic Footwear Fitting
Smartfitting
1 other identifier
interventional
30
1 country
1
Brief Summary
Patients with diabetes at high risk of ulceration require a perfect fitting shoe to avoid high shear and pressure forces. Neuropathy skews sensory perceptions and can alter the proper selection of the therapeutic footwear. The aims of study were to evaluate the ability of high-risk patients with diabetes in remission to select the proper therapeutic footwear and to validate a novel 3D foot scanner app for selecting the proper fitting therapeutic footwear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2022
CompletedFirst Posted
Study publicly available on registry
April 29, 2022
CompletedStudy Start
First participant enrolled
June 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2022
CompletedNovember 4, 2022
November 1, 2022
15 days
April 22, 2022
November 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure was the requirement of Therapeutic Footwear change after prescription because ill fitting.
Validation of proper therapeutic footwear fitting was performed by a specialized podiatrist after acquisition of shoes in both groups. TF was recommended to change when following ill fitting reason were found: excessive length or tight, or compromise with toes
1 week
Secondary Outcomes (1)
Number of participants with an ulcer occurrence event
1 month
Study Arms (2)
Standard Therapeutic Footwear prescription group
NO INTERVENTION1\) Patients that will acquire the therapeutic footwear size and model according to aesthetic preferences
Therapeutic Footwear prescription based on a 3D Foot scanner
EXPERIMENTAL2\) Patients that will acquire a specific size and model according to result of a novel mobile app 3D feet scan (smart-fitting by Podiapp - Podartis s.r.l Unipersonale-Crocceta del Montello (TV), Italy).
Interventions
The 3D foot scan becomes a movile app that recommends a specific size and model of therapeutic footwear according to the measurements
Eligibility Criteria
You may qualify if:
- High risk patients according to the International Working Group Diabetic Foot Guidelines (IWGDF-risk 3).
- Capability to walk autonomously without walking aids.
- Diabetic Peripheral neuropathy.
You may not qualify if:
- Major amputation in the contralateral limb (below or above the knee).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clínica Universitaria de Podología de la Universidad Complutense de Madrid
Madrid, 28040, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr
Study Record Dates
First Submitted
April 22, 2022
First Posted
April 29, 2022
Study Start
June 15, 2022
Primary Completion
June 30, 2022
Study Completion
July 15, 2022
Last Updated
November 4, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share